Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/511836
Title: Comparative study of qbd implementation perspective in india with other countries and application of aqbd in selected combined formulations
Researcher: Patel, Bhoomi D.
Guide(s): Vekaria, Hitesh J.
Keywords: Bilastine
Clinical Pre Clinical and Health
Efonidipine Hydrochloride Ethanolate
Method Validation
Montelukast sodium
Pharmacology and Pharmacy
Pharmacology and Toxicology
QbD
RP-HPLC
Telmisartan and Chlorthalidone
University: RK University
Completed Date: 2023
Abstract: quotBackground: Determination of drugs in combined pharmaceutical dosage forms without any interference from any common excipients is a major challenge faced today by many analysts. Quality is important in every product or service, but it is vital in medicines as it involves life. The present work describes simple, accurate and precise analytical methods for determination of selected combined dosage forms. newlineAim: To develop a simple, precise, and accurate Analytical methods by applying QbD approach for estimation of selected combined dosage forms and to validate the methods as per ICH guideline. newlineMaterials and Methods: Billargic M the fixed dose combination of Bilastine and Montelukast sodium, Efonta T fixed dose combination of Efonidipine Hydrochloride Ethanolate and Telmisartan, Efnocar CT fixed dose combination of Efonidipine Hydrochloride Ethanolate and Chlorthalidone was selected and raw materials were procured from the well-known sources. Instruments - UV, HPLC etc. will be used for analyzing the drug combinations. Various chemical like Acetonitrile, Methanol, Dipotassium phosphate buffer, OPA etc are used. newlineResults and Discussion: newlineA simple, accurate, rapid and precise reverse phase high performance liquid chromatographic method has been developed for the simultaneous determination of Bilastine (BST) and Montelukast sodium (MNT), Efonidipine Hydrochloride Ethanolate (EFE) and Telmisartan (TLM), Efonidipine Hydrochloride Ethanolate and Chlorthalidone (CHL). By using 32 Factorial design, 23 Factorial design and central composite design method have been developed and optimized, respectively. newlineConclusion: The AQbD based developed methods for Bilastine and Montelukast sodium, Efonidipine Hydrochloride Ethanolate and Telmisartan, Efonidipine Hydrochloride Ethanolate and Chlorthalidone were successfully validated as per ICH Q2 (R1) and from the results it was concluded that the present method was suitable for the routine estimation of the raw materials and in the pharmaceutical formulation.quot
Pagination: -
URI: http://hdl.handle.net/10603/511836
Appears in Departments:Faculty of Pharmacy

Files in This Item:
File Description SizeFormat 
01_title page.pdfAttached File83.14 kBAdobe PDFView/Open
02_prelim pages.pdf466.21 kBAdobe PDFView/Open
03_content.pdf22.53 kBAdobe PDFView/Open
04_abstract & graphical abstract.pdf97.67 kBAdobe PDFView/Open
05_chapter 1.pdf419.89 kBAdobe PDFView/Open
06_chapter 2.pdf12.83 kBAdobe PDFView/Open
07_chapter 3.pdf189.26 kBAdobe PDFView/Open
08_chapter 4.pdf1.14 MBAdobe PDFView/Open
09_chapter 5.pdf92.14 kBAdobe PDFView/Open
10_annexures.pdf466 kBAdobe PDFView/Open
11_recommendation.pdf174.83 kBAdobe PDFView/Open
12_urkund report.pdf30.44 kBAdobe PDFView/Open
80_recommendation.pdf177.67 kBAdobe PDFView/Open
Show full item record


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: